Skip to content

Vera Therapeutics VERA Purchases Of Property And Equipment Included In Accounts Payable

Purchases Of Property And Equipment Included In Accounts Payable at other companies

Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$110K-69.2%
Rigetti Computing, Inc. logo
Rigetti Computing, Inc.RGTI
$1.22M-13.2%
LifeStance Health Group logo
LifeStance Health GroupLFST
$2.49M+6.0%
Dave, Inc. logo
Dave, Inc.DAVE
$0-100%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$152K+92.4%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$706K-93.6%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept vera:PurchasesOfPropertyAndEquipmentIncludedInAccountsPayable.

The official record: Vera Therapeutics’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's purchases of property and equipment included in accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's purchases of property and equipment included in accounts payable?
Vera Therapeutics (VERA) reported purchases of property and equipment included in accounts payable of $63K in Q4 2025.
What does purchases of property and equipment included in accounts payable mean?
This metric represents capital expenditures for property and equipment that have been incurred but not yet settled in cash as of the reporting date. It captures non-cash investment activities by identifying liabilities recognized for asset acquisitions that will impact future cash flows. Monitoring this figure helps investors understand the company's committed capital investment obligations beyond what is reflected in current period cash outflows.